CANTON STRATEGIC HOLDINGS INC (CNTN)
Health Care · Digital asset treasury management and blockchain infrastructure; clinical-stage biotechnology · NASDAQ
A publicly traded digital asset treasury and blockchain infrastructure company that holds Canton Coin and operates validator nodes on the Canton Network, with legacy clinical-stage biotech research programs.
What CANTON STRATEGIC HOLDINGS INC does
Canton Strategic Holdings operates as the first publicly traded company focused on the Canton Network blockchain ecosystem, holding Canton Coin (CC) as a strategic digital asset reserve and operating as a Super Validator on the Canton Network to earn protocol-based rewards. The company pursues a digital asset treasury strategy that includes validator operations, investments in Canton Network applications and middleware, ecosystem collaboration, and capital-efficient token management through locking and lending programs. Additionally, the company maintains clinical-stage biotech research and development programs focused on inflammatory and immunologic conditions, though it shifted strategic priority away from biotech toward digital asset management in November 2025.
Themes: ["Digital asset treasury management","Blockchain infrastructure / Canton Network","Cryptocurrency / crypto ecosystem","Validator operations and protocol rewards","Institutional blockchain adoption","Clinical-stage biotech / inflammatory conditions","Capital markets digitization","Token-linked yield and DeFi strategies"]
Fundamentals
- Price$2.29 as of 2026-07-09 close
- Market cap$177M as of 2026-07-10
- 1-year return+31.8% as of 2026-07-09 close
- ROE-36.9% as of 2026-07-10
- Debt / equity0.00 as of 2026-07-10
- Beta1.50 as of 2026-07-10
Key risks (from latest filing)
["Highly volatile price fluctuation of Canton Coin and cryptocurrency markets, with stock price potentially highly correlated to digital asset holdings, creating significant valuation risk","Regulatory uncertainty regarding cryptocurrencies, blockchain, and digital assets, including inability to obtain necessary regulatory approvals for biotech product commercialization","Dependence on third parties for operations, network adoption, and successful execution of validator and investment strategy; Canton Network adoption risk and competitive pressure from alternative blockchain platforms"]
Competitors & peers
- MicroStrategy (MSTR) - digital asset treasury company
- Coinbase (COIN) - cryptocurrency exchange and blockchain infrastructure
- Marathon Digital Holdings (MARA) - Bitcoin mining and digital assets
- Grayscale Investments - digital asset investment products
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.